Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II: Review and perspective

Peritoneal Dialysis International

Volumn 33, Issue 1, 2013, Pages 8-14

  Nakayama, Masaaki ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiorenal syndrome type II; Congestive heart failure; Nonuremic indications

Indexed keywords

ANGIOTENSIN II; ARGIPRESSIN; CREATININE; DIURETIC AGENT; FUROSEMIDE; ICODEXTRIN; RENIN; SODIUM;

CARDIORENAL SYNDROME; CARDIORENAL SYNDROME TYPE II; CARDIORENAL SYNDROME TYPE IV; CENTRAL VENOUS PRESSURE; CONGESTIVE HEART FAILURE; DIASTOLIC HEART FAILURE; DISEASE CLASSIFICATION; DIURETIC THERAPY; HUMAN; HYPERURICEMIA; HYPOKALEMIA; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; MAINTENANCE THERAPY; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SYSTOLIC HEART FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; ULTRAFILTRATION; UREMIA;

CARDIO-RENAL SYNDROME; DECISION MAKING; HEART FAILURE; HUMANS; PERITONEAL DIALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 84878968717     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2012.00014     Document Type: Review

References (66)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123:e18-209.
2. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002; 13(Suppl 1):S37-40.
3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1):S1-266.
4. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 2088; 52:1527-39.
5. Kazory A, Ross EA. Ultrafiltration for decompensated heart failure: renal implications. Heart 2009; 95:1047-51.
6. Jois P, Mebazaa A. Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment. Semin Nephrol 2012; 32:26-30.
7. Mehrotra R. Peritoneal dialysis in adult patients without end-stage renal disease. Adv Perit Dial 2000; 16:67-72.
8. Próchnicka A, Olszowska A, Baczyński D, Zelichowski G, Wańkowicz Z. Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment. Pol Arch Med Wewn 2009; 119:815-19.
9. Jessup M, Brozena S. Heart failure. N Engl J Med 2003; 348:2007-18.
10. Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med 2004; 351:1097-105.
11. Ahmed A, Rich MW, Sanders PW, Perry GJ, Bakris GL, Zile MR, et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 2007; 99:393-8.
12. Sarraf M, Schrier RW. Cardiorenal syndrome in acute heart failure syndromes. Int J Nephrol 2011; 2011:293938.
13. Sarraf M, Masoumi A, Schrier RW. Cardiorenal syndrome in acute decompensated heart failure. Clin J Am Soc Nephrol 2009; 4:2013-26.
14. Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979; 236:F321-32.
15. Whitehouse T, Stotz M, Taylor V, Stidwill R, Singer M. Tissue oxygen and hemodynamics in renal medulla, cortex, and corticomedullary junction during hemorrhage-reperfusion. Am J Physiol Renal Physiol 2006; 291:F647-53.
16. Eckardt KU, Rosenberger C, Jürgensen JS, Wiesener MS. Role of hypoxia in the pathogenesis of renal disease. Blood Purif 2003; 21:253-7.
17. Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload in acute heart failure-re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 2008; 10:165-9.
18. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53:589-96.
19. Testani JM, Khera AV, St John Sutton MG, Keane MG, Wiegers SE, Shannon RP, et al. Effect of right ventricular function and venous congestion on cardio-renal interactions during the treatment of decompensated heart failure. Am J Cardiol 2010; 105:511-16.
20. Tanaka M, Yoshida H, Furuhashi M, Togashi N, Koyama M, Yamamoto S, et al. Deterioration of renal function by chronic heart failure is associated with congestion and oxidative stress in the tubulointerstitium. Intern Med 2011; 50:2877-87.
21. Colombo PC, Ganda A, Lin J, Onat D, Harxhi A, Iyasere JE, et al. Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome. Heart Fail Rev 2012; 17:177-90.
22. Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Prakash R, Swan HJ. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 1973; 288:1087-90.
23. Reungjui S, Pratipanawatr T, Johnson RJ, Nakagawa T. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia. Curr Opin Nephrol Hypertens 2008; 17:470-6.
24. Ellison DH. Diuretic therapy and resistance in congestive heart failure. Cardiology 2001; 96:132-43.
25. Silverstein ME, Ford CA, Lysaght MJ, Henderson LW. Treatment of severe fluid overload by ultrafiltration. N Engl J Med 1974; 291:747-51.
26. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, et al. on behalf of the UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49:675-83.
27. Schneierson SJ. Continuous peritoneal irrigation in the treatment of intractable edema of cardiac origin. Am J Med Sci 1949; 218:76-9.
28. Nora JJ, Trygstad CW, Mangos JA, Gibbons JE, Jegier W. Peritoneal dialysis in the treatment of intractable congestive heart failure of infancy and childhood. J Pediatr 1966; 68:693-8.
29. Mailloux LU, Swartz CD, Onesti G, Heider C, Ramirez O, Brest AN. Peritoneal dialysis for refractory congestive heart failure. JAMA 1967; 199:873-8.
30. Cairns KB, Porter GA, Kloster FE, Bristow JD, Griswold HE. Clinical and hemodynamic results of peritoneal dialysis for severe cardiac failure. Am Heart J 1968; 76:227-34.
31. Raja RM, Krasnoff SO, Moros JG, Kramer MS, Rosenbaum JL. Repeated peritoneal dialysis in treatment of heart failure. JAMA 1970; 213:2268-9.
32. Sharma BK, Chander M, Singh R, Chugh KS. Peritoneal dialysis in resistant congestive heart failure and pulmonary oedema. J Indian Med Assoc 1972; 58:159-62.
33. McKinnie JJ, Bourgeois RJ, Husserl FE. Long-term therapy for heart failure with continuous ambulatory peritoneal dialysis. Arch Intern Med 1985; 145:1128-9.
34. Rubin J, Ball R. Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases. Arch Intern Med 1986; 146:1533-5.
35. Shilo S, Slotki IN, Iaina A. Improved renal function following acute peritoneal dialysis in patients with intractable congestive heart failure. Isr J Med Sci 1987; 23:821-4.
36. König P, Geissler D, Lechleitner P, Spielberger M, Dittrich P. Improved management of congestive heart failure. Use of continuous ambulatory peritoneal dialysis. Arch Intern Med 1987; 147:1031-4.
37. König PS, Lhotta K, Kronenberg F, Joannidis M, Herold M. CAPD: a successful treatment in patients suffering from therapy-resistant congestive heart failure. Adv Perit Dial 1991; 7:97-101.
38. Tormey V, Conlon PJ, Farrell J, Horgan J, Walshe JJ. Long-term successful management of refractory congestive cardiac failure by intermittent ambulatory peritoneal ultrafiltration. QJM 1996; 89:681-3.
39. Stegmayr BG, Banga R, Lundberg L, Wikdahl AM, Plum-Wirell M. PD treatment for severe congestive heart failure. Perit Dial Int 1996; 16(Suppl 1):S231-5.
40. Ryckelynck JP, Lobbedez T, Valette B, Le Goff C, Mazouz O, Levaltier B, et al. Peritoneal ultrafiltration and refractory congestive heart failure. Adv Perit Dial 1997; 13:93-7.
41. Ryckelynck JP, Lobbedez T, Valette B, Le Goff C, Mazouz O, Levaltier B, et al. Peritoneal ultrafiltration and treatment-resistant heart failure. Nephrol Dial Transplant 1998; 13(Suppl 4):56-9.
42. Elhalel-Dranitzki M, Rubinger D, Moscovici A, Haviv YS, Friedlaender MM, Silver J, et al. CAPD to improve quality of life in patients with refractory heart failure. Nephrol Dial Transplant 1998; 13:3041-2.
43. Sheppard R, Panyon J, Pohwani AL, Kapoor A, Macgowan G, McNamara D, et al. Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure. J Card Fail 2004; 10:380-3.
44. Kagan A, Rapoport J. The role of peritoneal dialysis in the treatment of refractory heart failure. Nephrol Dial Transplant 2005; 20(Suppl 7):vii28-31.
45. Bertoli SV, Ciurlino D, Maccario M, Martino S, Bigatti G, Traversi L, et al. Home peritoneal ultrafiltration in patients with severe congestive heart failure without end-stage renal disease. Adv Perit Dial 2005; 21:123-7.
46. Gotloib L, Fudin R, Yakubovich M, Vienken J. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant 2005; 20(Suppl 7):vii32-6.
47. Takane H, Nakamoto H, Arima H, Shoda J, Moriwaki K, Ikeda N, et al. Continuous ambulatory peritoneal dialysis is effective for patients with severe congestive heart failure. Adv Perit Dial 2006; 22:141-6.
48. Phadke G, Mahale A, Ahlin T, Chemiti G, Levitski T. Continuous ambulatory peritoneal dialysis in a patient with isolated right heart failure and ascites: a case report. Adv Perit Dial 2008; 24:111-12.
49. Próchnicka A, Olszowska A, Baczyński D, Zelichowski G, Lubas A, Wiśniewska M, et al. Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment: case report. Pol Arch Med Wewn 2009; 119:834-7.
50. Basile C, Chimienti D, Bruno A, Cocola S, Libutti P, Teutonico A, et al. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure. Perit Dial Int 2009; 29:116-18.
51. Nakayama M, Nakano H, Nakayama M. Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis. J Cardiol 2010; 55:49-54.
52. Sánchez JE, Ortega T, Rodríguez C, Díaz-Molina B, Martín M, Garcia-Cueto C, et al. Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant 2010; 25:605-10.
53. Cnossen TT, Kooman JP, Konings CJ, Uszko-Lencer NH, Leunissen KM, van der Sande FM. Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure. Blood Purif 2010; 30:146-52.
54. Sens F, Schott-Pethelaz AM, Labeeuw M, Colin C, Villar E on behalf of the REIN Registry. Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure. Kidney Int 2011; 80:970-7.
55. Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ, Hiralall JK, de Waart DR, Struijk DG, et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50:979-86.
56. Flessner MF. Peritoneal ultrafiltration: mechanisms and measures. Contrib Nephrol 2006; 150:28-36.
57. Silverberg DS, Wexler D, Blum M, Sheps D, Schwartz D, Yachnin T, et al. Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases. Perit Dial Int 2001; 21(Suppl 3):S236-40.
58. Zemel D, Imholz AL, de Waart DR, Dinkla C, Struijk DG, Krediet RT. Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int 1994; 46:1422-30.
59. Costanzo MR, Saltzberg MT, Jessup M, Teerlink JR, Sobotka PA on behalf of the Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure (UNLOAD) Investigators. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail 2010; 16:277-84.
60. Ali SS, Olinger CC, Sobotka PA, Dahle TG, Bunte MC, Blake D, et al. Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion. Congest Heart Fail 2009; 15:1-4.
61. Ni J, Verbavatz JM, Rippe A, Boisdé I, Moulin P, Rippe B, et al. Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int 2006; 69:1518-25.
62. Nakayama M, Yokoyama K, Kubo H, Matsumoto H, Hasegawa T, Shigematsu T, et al. The effect of ultra-low sodium dialysate in CAPD. A kinetic and clinical analysis. Clin Nephrol 1996; 45:188-93.
63. Rustøen T, Howie J, Eidsmo I, Moum T. Hope in patients hospitalized with heart failure. Am J Crit Care 2005; 14:417-25.
64. Ota K, Akiba T, Nakao T, Nakayama M, Maeba T, Park MS, et al. on behalf of the Icodextrin Study Group. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients. Perit Dial Int 2003; 23:356-61.
65. Nakayama M, Kasai K, Imai H on behalf of TRM-280 Study Group. Novel low Na peritoneal dialysis solutions designed to optimize Na gap of effluent: kinetics of Na and water removal. Perit Dial Int 2009; 29:528-35.
66. Nakayama M. Fluid status and its management in Japanese peritoneal dialysis patients. Perit Dial Int 2006; 26:144-9.